ODF3B Promotes the Progression of Clear Cell Renal Cell Carcinoma via the JAK/STAT Signaling Pathway
Medical Science Monitor · 2026
DOI: 10.12659/msm.951100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2026. Verfasst von Yongyang Yun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Janus Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Peking University First Hospital, Beijing, China.
- Institution of Urology, Peking University, Beijing, China.
- National Urological Cancer Center, Beijing, China.
- Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, China.
ORCID-Profile: Yongyang Yun, Xing Ji, Yixiao Liu, Zhoujie Sun
Zitieren
APA
Yun, Y., Ji, X., Wu, T., Liu, Y., Li, Z., Sun, Z., Zhou, P., Yang, L., & Yu, W. (2026). ODF3B Promotes the Progression of Clear Cell Renal Cell Carcinoma via the JAK/STAT Signaling Pathway. Medical Science Monitor. https://doi.org/10.12659/msm.951100
Vancouver
Yun Y, Ji X, Wu T, Liu Y, Li Z, Sun Z, et al. ODF3B Promotes the Progression of Clear Cell Renal Cell Carcinoma via the JAK/STAT Signaling Pathway. Medical Science Monitor. 2026. doi:10.12659/msm.951100
BibTeX
@article{Yun2026,
author = {Yun, Yongyang and Ji, Xing and Wu, Tianyu and Liu, Yixiao and Li, Zheng and Sun, Zhoujie and Zhou, Peimin and Yang, Lei and Yu, Wei},
title = {ODF3B Promotes the Progression of Clear Cell Renal Cell Carcinoma via the JAK/STAT Signaling Pathway},
journal = {Medical Science Monitor},
year = {2026},
doi = {10.12659/msm.951100}
}
EUVIMED